Adam Bucki

17PUBLICATIONS
41CO-AUTHORS
Clinical pharmacology and therapeuticsBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsMolecular targetsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 29, 2025
Novel Dual 5-HT7 Antagonists and Sodium Channel Inhibitors as Potential Therapeutic Agents with Antidepressant and Anxiolytic Activities.

Anna Czopek, Paulina Koczurkiewicz-Adamczyk, Katarzyna Wójcik-Pszczoła

|Oct 29, 2025
JP-14: A Trace Amine-Associated Receptor 1 Agonist with Anti-Metabolic Disorder Potential.

Monika Marcinkowska, Joanna Sniecikowska, Monika Głuch-Lutwin

|Apr 23, 2025
Discovery of NLX-266, an Orally Available and Metabolically Stable ERK1/2-Biased 5-HT1AR Agonist with Superior Antidepressant and Antiparkinsonian Activity.

Joanna Sniecikowska, Monika Gluch-Lutwin, Adam Bucki

|Aug 19, 2024
Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation.

Izabella Góral, Tomasz Wichur, Emilia Sługocka

|Oct 23, 2023
Neuroprotective Activity of Enantiomers of Salsolinol and N-Methyl-(R)-salsolinol: In Vitro and In Silico Studies.

Magdalena Kurnik-Łucka, Gniewomir Latacz, Adam Bucki

|May 16, 2023
Application of automated machine learning in the identification of multi-target-directed ligands blocking PDE4B, PDE8A, and TRPA1 with potential use in the treatment of asthma and COPD.

Alicja Gawalska, Natalia Czub, Michał Sapa

Pageof 3

Frequent Collaborators

8 joint publications

Anna Więckowska

8 joint publications

Marcin Kolaczkowski

6 joint publications

Monika Marcinkowska

6 joint publications

Joanna Sniecikowska